Eli Lilly expands cancer tie-up in fast-growing China market
October 12, 2015 at 03:29 AM EDT
SHANGHAI, Oct 12 (Reuters) - Eli Lilly and Co has expanded a tie-up up with China-based biopharmaceutical company Innovent Biologics Inc to develop cancer treatments for the fast-growing Chinese market, the two companies said in a joint statement on Monday.
